Carlyle is purchasing $250 million of loans from FarmOp Capital, a lend that helps farmers deal with the seasonal flow of funds https://t.co/jThhigelhH ...

Company Overview - Carlyle Credit Income Fund (CCIF) is an externally managed closed-end fund focused on investing primarily in equity and junior debt tranches of collateralized loan obligations (CLOs) [3] - The CLOs are collateralized by a portfolio consisting mainly of U.S. senior secured loans with a diverse range of underlying borrowers across various industry sectors [3] - CCIF is managed by Carlyle Global Credit Investment Management L.L.C., a wholly owned subsidiary of Carlyle, leveraging Carlyle's significant scale and resources as one of the world's largest CLO managers [3] Financial Results Announcement - CCIF will release its financial results for the third quarter of 2025 after market close on August 19, 2025 [1] - A conference call to discuss the results will be held on August 20, 2025, at 10:00 a.m. EST [1] Carlyle Group Overview - Carlyle Group is a global investment firm with expertise in deploying private capital across three business segments: Global Private Equity, Global Credit, and Carlyle AlpInvest [4] - As of March 31, 2025, Carlyle has $453 billion in assets under management [4] - The firm employs over 2,300 people across 29 offices on four continents [4]

On Bullish with Sonali Basak, Carlyle CEO Harvey Schwartz reveals how he reached the pinnacle of Wall Street, and what private markets mean for the US economy. https://t.co/OP35hGgpJQ ...

Carlyle is buying a majority stake in Adastra in a deal valuing the IT consultancy and services provider at about $400 million including debt, according to people familiar with the matter https://t.co/z9kywAV7f3 ...

Core Insights - Acentra Health has appointed Marnie Keogh as Senior Vice President of Marketing to enhance its integrated marketing strategy and brand development [1][2] - Keogh has over 20 years of experience in healthcare marketing, previously serving at Magellan Health and Anthem, Inc., focusing on digital health and member engagement [2][3] - Acentra Health aims to modernize healthcare experiences through technology and clinical expertise, backed by Carlyle Group [4] Company Overview - Acentra Health specializes in technology and health solutions, targeting government and commercial healthcare clients [1] - The company combines public sector knowledge with clinical expertise to improve healthcare outcomes and efficiency [4] - Acentra Health is supported by Carlyle Group, a global investment firm, indicating strong financial backing [4] Leadership Insights - Marnie Keogh's leadership is expected to drive brand transformation and operational excellence within Acentra Health [2] - Keogh's background includes promoting generative artificial intelligence and digital health adoption, which aligns with Acentra's goals [2] - Her educational qualifications include an MBA and a bachelor's degree in computer science, enhancing her capability in the healthcare technology sector [3]

Core Insights - Carlyle Secured Lending Inc. (NASDAQ: CGBD) has faced a significant decline in portfolio quality and dividend payout ratio in the first quarter of 2025, raising concerns about the sustainability of its current dividend payments [1] Company Summary - The company has reported a substantial decrease in the quality of its investment portfolio, which may impact its financial stability and future dividend distributions [1]

Core Viewpoint - Centerra Gold Inc. is set to release its second quarter 2025 operating and financial results on August 6, 2025, followed by a conference call on August 7, 2025, at 9:00 a.m. Eastern Time [1]. Company Overview - Centerra Gold Inc. is a Canadian-based gold mining company focused on operating, developing, exploring, and acquiring gold and copper properties in North America, Türkiye, and other global markets [3]. - The company operates two mines: the Mount Milligan Mine in British Columbia, Canada, and the Öksüt Mine in Türkiye [3]. - Centerra also owns the Kemess Project in British Columbia, the Goldfield Project in Nevada, and operates a Molybdenum Business Unit in the United States and Canada [3]. - The company's shares are traded on the Toronto Stock Exchange (TSX) under the symbol CG and on the New York Stock Exchange (NYSE) under the symbol CGAU [3].

Carlyle is in talks to hand over the keys to Dainese to creditors HPS Investment Partners and Arcmont Asset Management, in one of the first potential private credit takeovers in Italy https://t.co/oNI6dVFGLx ...

Core Insights - Acentra Health has been recognized as the 43rd largest private company by revenue in the Washington, D.C. region according to the Washington Business Journal's 2025 list [1] - The company has shown significant growth, climbing 23 spots over the last four years, indicating sustained revenue growth and increased market share [2] Company Performance - Acentra Health's growth is attributed to strategic investments in technology and workforce, enhancing its service delivery and operational efficiency [2][4] - The company serves clients across all 50 states, partnering with 47 state Medicaid agencies and 25 federal agencies, impacting over 140 million beneficiaries [4] Leadership Statements - The CEO, Todd Stottlemyer, emphasized the company's commitment to innovation and its role as a vital partner in health solutions, combining technology, clinical insight, and policy fluency [3] - Meghan Harris, President & COO, highlighted the trust placed in Acentra Health by clients to address complex healthcare challenges, focusing on improving health outcomes for priority populations [4] Recognition and Awards - Acentra Health has received multiple accolades, including the Corporate Growth Award from the Association for Corporate Growth National Capital Chapter and a spot on the Fastest Growing Companies list by the Washington Business Journal in 2024 [5] Company Overview - Acentra Health integrates public sector knowledge, clinical expertise, and technological innovation to enhance healthcare experiences for various partners [6] - The company is backed by Carlyle, a global investment firm, which supports its mission to modernize healthcare solutions [6]

Macroeconomic Analysis - Higher interest rates are exposing imbalances, leading to an unwind of capital misallocation dating back to 2008 and potentially 1989 [1] - The US stimulus post-GFC attracted capital due to its financial infrastructure [2] - A major capital rotation towards Europe and the rest of the world is underway, rebalancing global capital flows [4] - Zero percent interest rate policies masked underlying imbalances, now exposed with rates at 45%-5% [20][21] - Global synchronous growth is possible due to stronger US performance, surprising Chinese retail sales and exports, and Europe releasing its debt brake on fiscal spending [28] Defense Spending and Industrial Policy - Europe's lack of a military-industrial complex has hindered its technological development [3] - Increased defense spending, potentially reaching $14 trillion, could stimulate a major CapEx boom cycle [4][5][6] - Private capital is crucial for efficiently allocating capital in Europe's defense sector, balancing control and market pressure [13][14] - Europe has a hidden defense sector with many dual-purpose companies, presenting investment opportunities [16] Energy Security and Transition - Energy security, not climate concerns, is driving investments in nuclear, solar, and EVs [17][18] - The US energy independence has changed its geopolitical calculations, particularly regarding the Middle East [22][23][24] - Underinvestment in key commodities like copper and lithium, coupled with misallocation of capital, suggests a potential reversal [31][33]